期刊文献+

不同病因肝内胆管癌行肝切除术预后与年龄的关系 被引量:2

Relationship between age and outcome of intrahepatic cholangiocarcinoma of different causative factors
下载PDF
导出
摘要 目的:探讨不同病因的肝内胆管癌(intrahepatic cholangiocarcinoma,ICC)患者行肝切除术预后与年龄之间的关系。方法:对东方肝胆外科医院2004至2010年期间行R0切除术的606名肝内胆管癌患者进行分析。将患者分为乙肝相关组(HBV-ICC,n=456),结石相关组(stone-ICC,n=75)及其他病因组(other-ICC,n=85)。按年龄分为青年组(<40岁)、中年组(40~60岁)及老年组(>60岁)。分别对不同年龄段不同病因的患者进行生存分析对比。结果:青年组及老年组两种病因的总生存期差异无统计学意义(P=0.236,P=0.151);而中年组两种病因总生存期差异有统计学意义(P=0.002);青年组及老年组两种病因的复发率差异无统计学意义(P=0.169,P=0.126),而中年组复发率差异有统计学意义(P=0.003)。结论:在不同年龄段的患者中,不同病因肝内胆管癌切除术后的生存及复发均存在差异。 Objective:To evaluate the impact of different causative factors of intrahepatic cholangiocarcinoma(ICC)on disease outcome related to age.Methods:Date of 606 consecutive patients undergoing R0 liver resection for ICC at the Eastern Hepatobiliary Surgery Hospital between 2004 and 2010 were analyzed.These patients were divided into a hepatitis B virus-related(HBV-ICC,n=456),a hepatolithiasis-related(stone-ICC,n=75),and an other etiologies-related(other-ICC,n=85)ICC groups.Patients were classified into 3 groups by age bracket;younger group(<40 years),middle-aged group(40–60 years),and elderly group(above 60 years).Results:The differences of overall survival in the younger group and the elderly group were all not statistically significant(P=0.236,P=0.151),while in the middle-aged group it was significant(P=0.002).Recurrence in the younger group and the elderly group showed no significant difference(P=0.169,P=0.126),but existed significance in the middle-aged group(P=0.003).Conclusion:In different age-related groups,outcome of different causative factors of ICC exist differences.
作者 李昊昱 陆丽华 夏勇 沈锋 李俊 LI Haoyu;LU Lihua;XIA Yong;SHEN Feng;LI Jun(Department of Hepatic Surgery IV,the Eastern Hepatobiliary Surgery Hospital,Navy Medical University,Shanghai 200438,China)
出处 《临床与病理杂志》 2019年第11期2418-2424,共7页 Journal of Clinical and Pathological Research
基金 国家自然科学基金(81772531) 上海市优秀学术/技术带头人计划(19XD1425000) 上海市科学技术委员会医学引导项目(18411968900)~~
关键词 肝内胆管癌 病因 年龄 intrahepatic cholangiocarcinoma causative factors age
  • 相关文献

参考文献1

二级参考文献9

  • 1E1- Serag HB, Marrero JA, Rudolph L, et al. Diagnosis and treat- ment of hepatocellular carcinoma [ J ]. Gastroenterology, 2008,134 (6) :1752 - 1763.
  • 2Chan AC,Poon RT, Ng KK, et al. Changing paradigm in the man- agement of hepatocellular carcinoma improves the survival benefit of early detection by screening [ J ]. Ann Surg, 2008,247 ( 4 ) : 666 - 673.
  • 3Tandon P, Garcia - Tsao G. Prognostic indicators in hepatocellular carcinoma : a systematic review of 72 studies [ J ]. Liver Int ,2009,29 (4) :502 -510.
  • 4Ohki T, Tateishi R. CT with hepatic arterioportography as a pre- treatment examination for hepatocellular carcinoma patients : a ran- domized controlled trial [ J ]. J Gastroenterol, 2013,108 ( 8 ) : 1305 -1313.
  • 5Chien - Wei Su, Hao - Jan Lei. The effect of age on the long - term prognosis of patients with hepatocellular carcinoma after resection surgery[ J ]. J Archsurg,2012,147 ( 2 ) : 137 - 144.
  • 6Chen YL, Chert CH. Elevated preoperative serum CA19 -9 levels in patients with hepatocellular carcinoma is associated with poor prognosis after resection[ J ]. Sci World J, 2013,1155 ( 10 ) : 255 - 261.
  • 7Mirici - Cappa F, Gramenzi A, Santi V, et al. Italian Liver Cancer Group. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20 - year muhicentre expe- rience[ J ]. Gut,2010,59 (3) :387 - 396.
  • 8Huang L, Li J. Antiviral therapy decreases viral reactivation in pa- tients with hepatitis B virus -related hepatocellular carcinomaun- dergoing hepatectomy : a randomized controlled trial [ J ]. J Viral Hepat,2013,20 (5) :336 - 342.
  • 9Chin R, Earnest - Silveira L, Koeberlein B, et al. Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus:fac- tors contributing to hepatocarcinogenesis [ J ]. J Hepatol, 2007,47 (3) :325 -337.

共引文献13

同被引文献20

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部